Window of opportunity trial to characterize the safety, pharmacokinetics, and pharmacodynamics of fosciclopirox (CPX-POM) in cisplatin-ineligible muscle invasive bladder cancer patients.

fosciclopirox (CPX-POM) - BioNOVUS, University of Kansas Medical Center

cisplatin - Generic mfg.

https://meetinglibrary.asco.org/record/184052

John Arthur Taylor; Robyn Wood; Tammy Ham; Crista Casey; Prasad Dandawate; Greg Reed; Benjamin L. Woolbright; Michael Jay Baltezor; Roy A. Jensen; Michael Dalton; Valentina Zhukova-Harrill; William McCulloch; Shrikant Anant; Scott James Weir

Dec 22, 2019